These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 33781630)
41. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Rouillac-Le Sciellour C; Puillandre P; Gillot R; Baulard C; Métral S; Le Van Kim C; Cartron JP; Colin Y; Brossard Y Mol Diagn; 2004; 8(1):23-31. PubMed ID: 15230639 [TBL] [Abstract][Full Text] [Related]
42. Practices for RhD alloimmunization prevention: a vignette-based survey of midwives. Jourdren G; Berveiller P; Rousseau A J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7629-7639. PubMed ID: 34433367 [TBL] [Abstract][Full Text] [Related]
43. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease]. Misković B; Stipoljev F; Hadzisejdić I; Grahovac B Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635 [TBL] [Abstract][Full Text] [Related]
44. [RHD variant in RhD/-/ mother with anti-D makes noninvasive fetal RHD genotyping impossible]. Orzińska A; Engel K; Łakomy M; Smolarczyk-Wodzyńska J; Lipińska A; Pelc-Kłopotowska M; Brojer E Ginekol Pol; 2009 Oct; 80(10):786-90. PubMed ID: 19943546 [TBL] [Abstract][Full Text] [Related]
45. Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA. Gönenç G; Işçi H; Yiğiter AB; Hançer V; Büyükdoğan M; Güdücü N; Dünder I Clin Exp Obstet Gynecol; 2015; 42(3):344-6. PubMed ID: 26152007 [TBL] [Abstract][Full Text] [Related]
46. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640 [TBL] [Abstract][Full Text] [Related]
47. A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales. Szczepura A; Osipenko L; Freeman K BMC Pregnancy Childbirth; 2011 Jan; 11():5. PubMed ID: 21244652 [TBL] [Abstract][Full Text] [Related]
48. Cell-Free DNA and Next-Generation Sequencing for Prenatal Diagnosis. Rieneck K Methods Mol Biol; 2024; 2753():583-609. PubMed ID: 38285369 [TBL] [Abstract][Full Text] [Related]
49. Confirmed non-invasive prenatal testing for foetal Rh blood group genotyping along with bi-allelic short insertion/deletion polymorphisms as a positive internal control. Armstrong-Fisher S; Koushki K; Mashayekhi K; Urbaniak SJ; van der Schoot E; Varzi AM Transfus Med; 2022 Apr; 32(2):141-152. PubMed ID: 35261100 [TBL] [Abstract][Full Text] [Related]
50. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461 [TBL] [Abstract][Full Text] [Related]
51. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD. Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165 [TBL] [Abstract][Full Text] [Related]
53. Early detection of RhD status in pregnancies at risk of hemolytic disease of the newborn. Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Racca A Clin Exp Med; 2002 Jul; 2(2):77-81. PubMed ID: 12141530 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of non-invasive prenatal RHD genotyping of the fetus. Hyland CA; Gardener GJ; Davies H; Ahvenainen M; Flower RL; Irwin D; Morris JM; Ward CM; Hyett JA Med J Aust; 2009 Jul; 191(1):21-5. PubMed ID: 19580531 [TBL] [Abstract][Full Text] [Related]
55. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007 [TBL] [Abstract][Full Text] [Related]
57. Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Daniels G; Finning K; Martin P; Massey E Prenat Diagn; 2009 Feb; 29(2):101-7. PubMed ID: 19085963 [TBL] [Abstract][Full Text] [Related]
58. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation. Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127 [TBL] [Abstract][Full Text] [Related]
59. Fetal RhD genotyping from maternal plasma. Lo YM Ann Med; 1999 Oct; 31(5):308-12. PubMed ID: 10574502 [TBL] [Abstract][Full Text] [Related]
60. Fetal RHD detection from circulating cell-free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA. Londero D; Stampalija T; Bolzicco D; Castro Silva E; Candolini M; Cortivo C; Dreossi C; Fantasia I; Pecile V; De Angelis V Transfus Med; 2019 Dec; 29(6):408-414. PubMed ID: 31209986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]